COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 690 | 14 | 730 | 79 | 962 | 153 | 931 |
ERLYTX | 62 | 2 | 104 | 4 | 49 | 11 | 67 |
GI | 213 | 1 | 52 | 14 | 170 | 30 | 183 |
GU | 522 | 8 | 417 | 44 | 536 | 81 | 493 |
LEUK | 87 | 1 | 52 | 10 | 122 | 20 | 122 |
LUNG | 635 | 4 | 209 | 9 | 110 | 22 | 134 |
LYMPH | 286 | 12 | 626 | 41 | 499 | 79 | 481 |
MELAN | 429 | 7 | 365 | 34 | 414 | 69 | 420 |
MMYEL | 325 | 1 | 52 | 11 | 134 | 31 | 189 |
MULT | 23 | 0 | 0 | 0 | 0 | 0 | 0 |
OTHER | 49 | 0 | 0 | 2 | 24 | 3 | 18 |
PREV | 8 | 1 | 52 | 2 | 24 | 2 | 12 |
SXQOL | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3335 | 51 | 2659 | 250 | 3044 | 501 | 3050 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
CCD | 580 | 2 | 104 | 12 | 146 | 20 | 122 |
ERLYTX | 5 | 1 | 52 | 2 | 24 | 2 | 12 |
GU | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
LEUK | 393 | 8 | 417 | 65 | 791 | 141 | 858 |
LUNG | 276 | 0 | 0 | 15 | 183 | 37 | 225 |
OTHER | 16 | 0 | 0 | 0 | 0 | 2 | 12 |
PEOLC | 22 | 1 | 52 | 9 | 110 | 17 | 103 |
PREV | 396 | 7 | 365 | 27 | 329 | 33 | 201 |
SXQOL | 801 | 10 | 522 | 51 | 621 | 86 | 524 |
Total | 2493 | 29 | 1512 | 181 | 2204 | 338 | 2057 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 690 | 14 | 730 | 79 | 962 | 153 | 931 |
CCD | 580 | 2 | 104 | 12 | 146 | 20 | 122 |
ERLYTX | 67 | 3 | 157 | 6 | 73 | 13 | 79 |
GI | 213 | 1 | 52 | 14 | 170 | 30 | 183 |
GU | 526 | 8 | 417 | 44 | 536 | 81 | 493 |
LEUK | 480 | 9 | 470 | 75 | 913 | 161 | 980 |
LUNG | 911 | 4 | 209 | 24 | 292 | 59 | 359 |
LYMPH | 286 | 12 | 626 | 41 | 499 | 79 | 481 |
MELAN | 429 | 7 | 365 | 34 | 414 | 69 | 420 |
MMYEL | 325 | 1 | 52 | 11 | 134 | 31 | 189 |
MULT | 23 | 0 | 0 | 0 | 0 | 0 | 0 |
OTHER | 65 | 0 | 0 | 2 | 24 | 5 | 30 |
PEOLC | 22 | 1 | 52 | 9 | 110 | 17 | 103 |
PREV | 404 | 8 | 417 | 29 | 353 | 35 | 213 |
SXQOL | 807 | 10 | 522 | 51 | 621 | 86 | 524 |
Total | 5828 | 80 | 4173 | 431 | 5247 | 839 | 5107 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 402 | 7 | 365 | 48 | 584 | 93 | 566 |
ERLYTX | 36 | 2 | 104 | 2 | 24 | 5 | 30 |
GI | 174 | 1 | 52 | 9 | 110 | 21 | 128 |
GU | 456 | 6 | 313 | 41 | 499 | 74 | 450 |
LEUK | 57 | 1 | 52 | 6 | 73 | 12 | 73 |
LUNG | 390 | 3 | 157 | 5 | 61 | 16 | 97 |
LYMPH | 201 | 10 | 522 | 27 | 329 | 52 | 317 |
MELAN | 248 | 4 | 209 | 22 | 268 | 43 | 262 |
MMYEL | 205 | 0 | 0 | 8 | 97 | 19 | 116 |
MULT | 13 | 0 | 0 | 0 | 0 | 0 | 0 |
OTHER | 49 | 0 | 0 | 2 | 24 | 3 | 18 |
PREV | 8 | 1 | 52 | 2 | 24 | 2 | 12 |
SXQOL | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2245 | 35 | 1826 | 172 | 2093 | 340 | 2069 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
CCD | 485 | 1 | 52 | 11 | 134 | 19 | 116 |
ERLYTX | 5 | 1 | 52 | 2 | 24 | 2 | 12 |
GU | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
LEUK | 170 | 0 | 0 | 19 | 231 | 52 | 317 |
LUNG | 143 | 0 | 0 | 8 | 97 | 18 | 110 |
OTHER | 16 | 0 | 0 | 0 | 0 | 2 | 12 |
PEOLC | 15 | 1 | 52 | 5 | 61 | 11 | 67 |
PREV | 351 | 5 | 261 | 25 | 304 | 31 | 189 |
SXQOL | 544 | 8 | 417 | 33 | 402 | 62 | 377 |
Total | 1733 | 16 | 834 | 103 | 1253 | 197 | 1200 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 550 | 9 | 470 | 70 | 852 | 123 | 749 |
CCD | 508 | 2 | 104 | 14 | 170 | 27 | 164 |
ERLYTX | 41 | 3 | 157 | 4 | 49 | 7 | 43 |
GI | 177 | 1 | 52 | 10 | 122 | 19 | 116 |
GU | 477 | 5 | 261 | 44 | 536 | 76 | 463 |
LEUK | 227 | 1 | 52 | 25 | 304 | 64 | 390 |
LUNG | 533 | 3 | 157 | 13 | 158 | 34 | 207 |
LYMPH | 201 | 10 | 522 | 27 | 329 | 52 | 317 |
MELAN | 248 | 4 | 209 | 22 | 268 | 43 | 262 |
MMYEL | 208 | 0 | 0 | 6 | 73 | 8 | 49 |
MULT | 14 | 0 | 0 | 0 | 0 | 0 | 0 |
OTHER | 162 | 4 | 209 | 24 | 292 | 45 | 274 |
PEOLC | 24 | 1 | 52 | 7 | 85 | 12 | 73 |
PREV | 359 | 6 | 313 | 27 | 329 | 33 | 201 |
SURV | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
SXQOL | 550 | 8 | 417 | 33 | 402 | 62 | 377 |
Total | 4280 | 57 | 2975 | 326 | 3969 | 605 | 3685 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 609 | 12 | 626 | 65 | 791 | 130 | 791 |
ERLYTX | 61 | 2 | 104 | 4 | 49 | 11 | 67 |
GI | 107 | 0 | 0 | 10 | 122 | 18 | 110 |
GU | 236 | 6 | 313 | 27 | 329 | 43 | 262 |
LEUK | 61 | 0 | 0 | 7 | 85 | 16 | 97 |
LUNG | 607 | 2 | 104 | 7 | 85 | 17 | 103 |
LYMPH | 203 | 7 | 365 | 30 | 365 | 60 | 365 |
MELAN | 5 | 0 | 0 | 0 | 0 | 0 | 0 |
MMYEL | 311 | 1 | 52 | 11 | 134 | 31 | 189 |
MULT | 23 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2223 | 30 | 1564 | 161 | 1960 | 326 | 1984 |
Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
Member | 2047 | 33 | 1722 | 156 | 1899 | 305 | 1857 |
AFFIL | 215 | 0 | 0 | 12 | 146 | 18 | 110 |
CCOP/NCORP | 1716 | 18 | 939 | 107 | 1303 | 214 | 1303 |
Non-SWOG | 1844 | 23 | 1200 | 150 | 1826 | 296 | 1802 |
Total | 5822 | 74 | 3861 | 425 | 5174 | 833 | 5072 |
ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
---|---|---|---|---|---|
LUNG | S2414 | NSCLC, Stg II-IIIB, Durva vs Surveillance | 1 | Y | 14-MAR-25 |
ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
---|---|---|---|---|---|
GU | EA8171 | PROS, newly diagnosed, mpMRI for pre-op stagi | 1 | E | 28-FEB-25 |
LUNG | A151216 | ALCHEMIST0 - screening | 0 | E | 14-MAR-25 |
LUNG | A151216 | ALCHEMIST0 - screening | 1 | E | 14-MAR-25 |
GI | A022001 | PANC, METS, Lu 177 Dotatate PRRT vs CAPTEM | 1 | E | 10-MAR-25 |
ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
---|---|---|---|---|
BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 10 |
BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 9 |
LEUK | MYELOMATCH | MSRP for the NCI myeloMATCH Clinical Trials | 1 | 8 |
MELAN | S2015 | MELAN, Stg I-II, 1cm v 2cm excision margins | 1 | 7 |
SXQOL | S2013 | I-CHECKIT: ICI toxicity risk prediction study | 1 | 6 |
LYMPH | S2308 | FL, LTB, Mosunetuzumab vs Rituximab | 1 | 6 |
OTHER | 10323 | Moonshot Biobank Research | 1 | 4 |
PREV | A212102 | Blind Ref Set for Multicancer Early Detection | 1 | 4 |
LYMPH | AHOD2131 | cHL,StgI-II,StdTherapyvImmuno-oncologyTherapy | 1 | 4 |
GU | A032103 | Urothelial, All Stg, MRD-Based Adj Tx | 0 | 3 |
PREV | NRGCC005 | Colon,Non-AdvancedAdenomas,Colonoscopy5v10yrs | 1 | 3 |
GU | S1802 | Pros, Stg IV, SST ± Surg/RT to Primary Tum | 1 | 3 |
SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 3 |
BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 2 | 3 |